Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Biologics
Revenue, means the sales value of Biologics
This report studies sales (consumption) of Biologics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biologics in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Monoclonal Antibodies (MAb) Technology
Recombinant DNA Technology (rDNA Technology)
Nuclear Magnetic Resonance (NMR) Technology
Chromatography
Electrophoresis
Mass Spectrometry
Western Blotting
Bioassay
Split by applications, this report focuses on sales, market share and growth rate of Biologics in each application, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Global Biologics Sales Market Report 2017
1 Biologics Overview
1.1 Product Overview and Scope of Biologics
1.2 Classification of Biologics
1.2.1 Monoclonal Antibodies (MAb) Technology
1.2.2 Recombinant DNA Technology (rDNA Technology)
1.2.3 Nuclear Magnetic Resonance (NMR) Technology
1.2.4 Chromatography
1.2.5 Electrophoresis
1.2.6 Mass Spectrometry
1.2.7 Western Blotting
1.2.8 Bioassay
1.3 Application of Biologics
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Biologics Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biologics (2012-2022)
1.5.1 Global Biologics Sales and Growth Rate (2012-2022)
1.5.2 Global Biologics Revenue and Growth Rate (2012-2022)
2 Global Biologics Competition by Manufacturers, Type and Application
2.1 Global Biologics Market Competition by Manufacturers
2.1.1 Global Biologics Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Biologics Revenue and Share by Manufacturers (2012-2017)
2.2 Global Biologics (Volume and Value) by Type
2.2.1 Global Biologics Sales and Market Share by Type (2012-2017)
2.2.2 Global Biologics Revenue and Market Share by Type (2012-2017)
2.3 Global Biologics (Volume and Value) by Regions
2.3.1 Global Biologics Sales and Market Share by Regions (2012-2017)
2.3.2 Global Biologics Revenue and Market Share by Regions (2012-2017)
2.4 Global Biologics (Volume) by Application
3 United States Biologics (Volume, Value and Sales Price)
3.1 United States Biologics Sales and Value (2012-2017)
3.1.1 United States Biologics Sales and Growth Rate (2012-2017)
3.1.2 United States Biologics Revenue and Growth Rate (2012-2017)
3.1.3 United States Biologics Sales Price Trend (2012-2017)
3.2 United States Biologics Sales and Market Share by Manufacturers
3.3 United States Biologics Sales and Market Share by Type
3.4 United States Biologics Sales and Market Share by Application
4 China Biologics (Volume, Value and Sales Price)
4.1 China Biologics Sales and Value (2012-2017)
4.1.1 China Biologics Sales and Growth Rate (2012-2017)
4.1.2 China Biologics Revenue and Growth Rate (2012-2017)
4.1.3 China Biologics Sales Price Trend (2012-2017)
4.2 China Biologics Sales and Market Share by Manufacturers
4.3 China Biologics Sales and Market Share by Type
4.4 China Biologics Sales and Market Share by Application
5 Europe Biologics (Volume, Value and Sales Price)
5.1 Europe Biologics Sales and Value (2012-2017)
5.1.1 Europe Biologics Sales and Growth Rate (2012-2017)
5.1.2 Europe Biologics Revenue and Growth Rate (2012-2017)
5.1.3 Europe Biologics Sales Price Trend (2012-2017)
5.2 Europe Biologics Sales and Market Share by Manufacturers
5.3 Europe Biologics Sales and Market Share by Type
5.4 Europe Biologics Sales and Market Share by Application
6 Japan Biologics (Volume, Value and Sales Price)
6.1 Japan Biologics Sales and Value (2012-2017)
6.1.1 Japan Biologics Sales and Growth Rate (2012-2017)
6.1.2 Japan Biologics Revenue and Growth Rate (2012-2017)
6.1.3 Japan Biologics Sales Price Trend (2012-2017)
6.2 Japan Biologics Sales and Market Share by Manufacturers
6.3 Japan Biologics Sales and Market Share by Type
6.4 Japan Biologics Sales and Market Share by Application
7 Southeast Asia Biologics (Volume, Value and Sales Price)
7.1 Southeast Asia Biologics Sales and Value (2012-2017)
7.1.1 Southeast Asia Biologics Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Biologics Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Biologics Sales Price Trend (2012-2017)
7.2 Southeast Asia Biologics Sales and Market Share by Manufacturers
7.3 Southeast Asia Biologics Sales and Market Share by Type
7.4 Southeast Asia Biologics Sales and Market Share by Application
8 India Biologics (Volume, Value and Sales Price)
8.1 India Biologics Sales and Value (2012-2017)
8.1.1 India Biologics Sales and Growth Rate (2012-2017)
8.1.2 India Biologics Revenue and Growth Rate (2012-2017)
8.1.3 India Biologics Sales Price Trend (2012-2017)
8.2 India Biologics Sales and Market Share by Manufacturers
8.3 India Biologics Sales and Market Share by Type
8.4 India Biologics Sales and Market Share by Application
9 Global Biologics Manufacturers Analysis
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biologics Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Biologics Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Roche Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Amgen
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Biologics Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Amgen Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 AbbVie
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Biologics Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 AbbVie Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Biologics Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Biologics Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Johnson & Johnson Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Biologics Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novo Nordisk Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Biologics Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Merck
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Biologics Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Merck Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Lilly
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Biologics Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Lilly Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 3sbio
9.12 Changchun high tech
9.13 CP Guojian Pharmacy
9.14 Biotech Pharma
9.15 Gelgen Biopharma
9.16 Sandoz
9.17 Teva
9.18 Hospira
9.19 Mylan
9.20 3sbio
9.21 Changchun high tech
9.22 CP Guojian Pharmacy
9.23 Biotech Pharma
9.24 Gelgen Biopharma
10 Biologics Maufacturing Cost Analysis
10.1 Biologics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biologics
10.3 Manufacturing Process Analysis of Biologics
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biologics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Biologics Market Forecast (2017-2022)
14.1 Global Biologics Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Biologics Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Biologics Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Biologics Price and Trend Forecast (2017-2022)
14.2 Global Biologics Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Biologics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biologics Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Biologics Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Biologics
Table Classification of Biologics
Figure Global Sales Market Share of Biologics by Type in 2015
Figure Monoclonal Antibodies (MAb) Technology Picture
Figure Recombinant DNA Technology (rDNA Technology) Picture
Figure Nuclear Magnetic Resonance (NMR) Technology Picture
Figure Chromatography Picture
Figure Electrophoresis Picture
Figure Mass Spectrometry Picture
Figure Western Blotting Picture
Figure Bioassay Picture
Table Applications of Biologics
Figure Global Sales Market Share of Biologics by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure United States Biologics Revenue and Growth Rate (2012-2022)
Figure China Biologics Revenue and Growth Rate (2012-2022)
Figure Europe Biologics Revenue and Growth Rate (2012-2022)
Figure Japan Biologics Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Biologics Revenue and Growth Rate (2012-2022)
Figure India Biologics Revenue and Growth Rate (2012-2022)
Figure Global Biologics Sales and Growth Rate (2012-2022)
Figure Global Biologics Revenue and Growth Rate (2012-2022)
Table Global Biologics Sales of Key Manufacturers (2012-2017)
Table Global Biologics Sales Share by Manufacturers (2012-2017)
Figure 2015 Biologics Sales Share by Manufacturers
Figure 2016 Biologics Sales Share by Manufacturers
Table Global Biologics Revenue by Manufacturers (2012-2017)
Table Global Biologics Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biologics Revenue Share by Manufacturers
Table 2016 Global Biologics Revenue Share by Manufacturers
Table Global Biologics Sales and Market Share by Type (2012-2017)
Table Global Biologics Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologics by Type (2012-2017)
Figure Global Biologics Sales Growth Rate by Type (2012-2017)
Table Global Biologics Revenue and Market Share by Type (2012-2017)
Table Global Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics by Type (2012-2017)
Figure Global Biologics Revenue Growth Rate by Type (2012-2017)
Table Global Biologics Sales and Market Share by Regions (2012-2017)
Table Global Biologics Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biologics by Regions (2012-2017)
Figure Global Biologics Sales Growth Rate by Regions (2012-2017)
Table Global Biologics Revenue and Market Share by Regions (2012-2017)
Table Global Biologics Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biologics by Regions (2012-2017)
Figure Global Biologics Revenue Growth Rate by Regions (2012-2017)
Table Global Biologics Sales and Market Share by Application (2012-2017)
Table Global Biologics Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologics by Application (2012-2017)
Figure Global Biologics Sales Growth Rate by Application (2012-2017)
Figure United States Biologics Sales and Growth Rate (2012-2017)
Figure United States Biologics Revenue and Growth Rate (2012-2017)
Figure United States Biologics Sales Price Trend (2012-2017)
Table United States Biologics Sales by Manufacturers (2012-2017)
Table United States Biologics Market Share by Manufacturers (2012-2017)
Table United States Biologics Sales by Type (2012-2017)
Table United States Biologics Market Share by Type (2012-2017)
Table United States Biologics Sales by Application (2012-2017)
Table United States Biologics Market Share by Application (2012-2017)
Figure China Biologics Sales and Growth Rate (2012-2017)
Figure China Biologics Revenue and Growth Rate (2012-2017)
Figure China Biologics Sales Price Trend (2012-2017)
Table China Biologics Sales by Manufacturers (2012-2017)
Table China Biologics Market Share by Manufacturers (2012-2017)
Table China Biologics Sales by Type (2012-2017)
Table China Biologics Market Share by Type (2012-2017)
Table China Biologics Sales by Application (2012-2017)
Table China Biologics Market Share by Application (2012-2017)
Figure Europe Biologics Sales and Growth Rate (2012-2017)
Figure Europe Biologics Revenue and Growth Rate (2012-2017)
Figure Europe Biologics Sales Price Trend (2012-2017)
Table Europe Biologics Sales by Manufacturers (2012-2017)
Table Europe Biologics Market Share by Manufacturers (2012-2017)
Table Europe Biologics Sales by Type (2012-2017)
Table Europe Biologics Market Share by Type (2012-2017)
Table Europe Biologics Sales by Application (2012-2017)
Table Europe Biologics Market Share by Application (2012-2017)
Figure Japan Biologics Sales and Growth Rate (2012-2017)
Figure Japan Biologics Revenue and Growth Rate (2012-2017)
Figure Japan Biologics Sales Price Trend (2012-2017)
Table Japan Biologics Sales by Manufacturers (2012-2017)
Table Japan Biologics Market Share by Manufacturers (2012-2017)
Table Japan Biologics Sales by Type (2012-2017)
Table Japan Biologics Market Share by Type (2012-2017)
Table Japan Biologics Sales by Application (2012-2017)
Table Japan Biologics Market Share by Application (2012-2017)
Figure Southeast Asia Biologics Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biologics Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Biologics Sales Price Trend (2012-2017)
Table Southeast Asia Biologics Sales by Manufacturers (2012-2017)
Table Southeast Asia Biologics Market Share by Manufacturers (2012-2017)
Table Southeast Asia Biologics Sales by Type (2012-2017)
Table Southeast Asia Biologics Market Share by Type (2012-2017)
Table Southeast Asia Biologics Sales by Application (2012-2017)
Table Southeast Asia Biologics Market Share by Application (2012-2017)
Figure India Biologics Sales and Growth Rate (2012-2017)
Figure India Biologics Revenue and Growth Rate (2012-2017)
Figure India Biologics Sales Price Trend (2012-2017)
Table India Biologics Sales by Manufacturers (2012-2017)
Table India Biologics Market Share by Manufacturers (2012-2017)
Table India Biologics Sales by Type (2012-2017)
Table India Biologics Market Share by Type (2012-2017)
Table India Biologics Sales by Application (2012-2017)
Table India Biologics Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Biologics Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biologics Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Biologics Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Biologics Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Biologics Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Biologics Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Biologics Global Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lilly Biologics Global Market Share (2012-2017)
Table 3sbio Basic Information List
Table Changchun high tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Sandoz Basic Information List
Table Teva Basic Information List
Table Hospira Basic Information List
Table Mylan Basic Information List
Table 3sbio Basic Information List
Table Changchun high tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics
Figure Manufacturing Process Analysis of Biologics
Figure Biologics Industrial Chain Analysis
Table Raw Materials Sources of Biologics Major Manufacturers in 2015
Table Major Buyers of Biologics
Table Distributors/Traders List
Figure Global Biologics Sales and Growth Rate Forecast (2017-2022)
Figure Global Biologics Revenue and Growth Rate Forecast (2017-2022)
Table Global Biologics Sales Forecast by Regions (2017-2022)
Table Global Biologics Sales Forecast by Type (2017-2022)
Table Global Biologics Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...